Literature DB >> 7167806

A comparison of denaturation and inactivation rates of creatine kinase in guanidine solutions.

Q Z Yao, H M Zhou, L X Hou, C G Zou.   

Abstract

Both the denaturation, as followed by UV absorbance and fluorescence changes, and inactivation of creatine kinase in guanidine solutions have been found to be first order reactions. In 3 M guanidine, at 30 degrees C, the inactivation rate constant was found to be 5.9 sec-1 and the denaturation rate constant 1.9 sec-1. At lower guanidine concentrations, the inactivation rate constants were only little affected whereas the denaturation rate constants decreased markedly, being of the order of 0.04 in 1 M and 0.004 in 0.5 M guanidine. The kinetics of the inactivation reaction in 0.5 M guanidine was found to be in agreement with a combination of two first order reactions. The enzyme lost activity first by a fast reaction with a rate constant only slightly lower than the rate constant in 3 M guanidine followed by a slower reaction with a rate constant of 0.003 sec-1. In 0.3 M guanidine, very little change in either UV absorbance or in fluorescence was observed, but, in sharp contrast, the enzyme lost considerable activity by a fast reaction and this was followed by a slower reaction of inactivation. Even after prolonged denaturation in 0.5 and 0.3 M guanidine, residual activities of 3.4% and 30% remained respectively. The above results suggest a very fragile active site although dissociation of the dimer and reversible guanidine inhibition may also contribute to the initial rapid inactivation. It is also to be noted that the multiphasic courses of inactivation at lower guanidine concentrations seem to suggest the presence of partly active intermediates during denaturation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7167806

Source DB:  PubMed          Journal:  Sci Sin B        ISSN: 0253-5823


  8 in total

1.  Chaperone-like effect of the linker on the isolated C-terminal domain of rabbit muscle creatine kinase.

Authors:  Zhe Chen; Xiang-Jun Chen; Mengdie Xia; Hua-Wei He; Sha Wang; Huihui Liu; Haipeng Gong; Yong-Bin Yan
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

2.  Effects of the Fc-III tag on activity and stability of green fluorescent protein and human muscle creatine kinase.

Authors:  Shan Feng; Yiyi Gong; Gulishana Adilijiang; Haiteng Deng
Journal:  Protein Sci       Date:  2013-07       Impact factor: 6.725

3.  Sequential events in the irreversible thermal denaturation of human brain-type creatine kinase by spectroscopic methods.

Authors:  Yan-Song Gao; Jing-Tan Su; Yong-Bin Yan
Journal:  Int J Mol Sci       Date:  2010-06-25       Impact factor: 5.923

4.  Conformational changes at the active site of creatine kinase at low concentrations of guanidinium chloride.

Authors:  H M Zhou; X H Zhang; Y Yin; C L Tsou
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

5.  Dissimilarity in the folding of human cytosolic creatine kinase isoenzymes.

Authors:  Yin Wang; Sha Wang; Yan-Song Gao; Zhe Chen; Hai-Meng Zhou; Yong-Bin Yan
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

6.  A single residue substitution accounts for the significant difference in thermostability between two isoforms of human cytosolic creatine kinase.

Authors:  Huihui Liu; Yan-Song Gao; Xiang-Jun Chen; Zhe Chen; Hai-Meng Zhou; Yong-Bin Yan; Haipeng Gong
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

7.  Effects of acrylamide on the activity and structure of human brain creatine kinase.

Authors:  Qing Sheng; He-Chang Zou; Zhi-Rong Lü; Fei Zou; Yong-Doo Park; Yong-Bin Yan; Shan-Jing Yao
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

8.  Effect of SNPs on creatine kinase structure and function: identifying potential molecular mechanisms for possible creatine kinase deficiency diseases.

Authors:  Chang Li; Qian Zhang; Wei-Jiang Hu; Hang Mu; Zong Lin; Long Ma; Yong-Doo Park; Hai-Meng Zhou
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.